Silverarc Capital Management »

Reviva Pharmaceutcls Hldgs I shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Reviva Pharmaceutcls Hldgs I (RVPH) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Reviva Pharmaceutcls Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceutcls Hldgs I held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceutcls Hldgs I by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.8M 564k 4.88

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Reviva Pharmaceutcls Hldgs I

Vanguard Group
Millennium Management
Susquehanna International
Citadel Advisors
Polar Securities
EMC Capital Management
Colony
Caption Management
BlackRock
Man Group
Two Sigma Investments
Marshall Wace
Jpmorgan Chase & Co
Jane Street
Virtu Financial

View all funds holding Reviva Pharmaceutcls Hldgs I